Search

everythinglearnresearchcommunity

for

Search:↓

Neoplasms hide in hair follicles to avoid the immune system.

PROTACs show promise for cancer treatment, but designing them effectively is challenging.

The type of tumor suppressor affects the form of skin cancer from hair follicle stem cells.

Understanding phenotypic plasticity is crucial for developing effective cancer therapies.

Targeting METTL1 may help slow papillary thyroid cancer growth and spread.

NKIRAS2 can suppress certain skin tumors but its effect on cancer varies with context and expression level.

The type of tumor suppressor gene lost affects the behavior of skin cancer.

Inactive hair follicle stem cells help prevent skin cancer.

Oncogenic K-ras causes rapid cancerous changes in the mouth's lining.

YAP and TAZ proteins are necessary for the development of two types of skin cancer.

Hair follicle regeneration may slow tumor growth.

Different types of stem cells exist within individual skin layers, and they can adapt to damage, transplantation, or tumor growth. These cells are regulated by their environment and genetic factors. Tumor growth is driven by expanding, genetically altered cells, not long-lived mutant stem cells. There's evidence of cancer stem cells in skin tumors. Other cells, bacteria, and genetic factors help maintain balance and contribute to disease progression. A method for growing mini organs from single cells has been developed.

Ultrasound-based radiomics and radiogenomics can improve ovarian cancer diagnosis and treatment, but need better standardization and AI tools.

Afatinib, neratinib, and zanubrutinib could be effective against KRASG12C-mutant tumors.

Cancer risk is linked to the balance of mutations and environmental factors, not just the number of mutations.

Peptide-based PROTACs show promise in targeting hard-to-treat proteins, especially for cancer therapy.

Normal cells outcompete and remove mutant cells in the pancreas with the help of the EphA2 receptor.

sPLA2-IIA increases growth in hair follicle stem cells and cancer cells, suggesting it could be targeted for hair growth and cancer treatment.

CRISPR/Cas systems show promise for cancer treatment by targeting miRNAs, but delivery and specificity challenges remain.

Understanding where cancer cells come from helps create better prevention and treatment methods.

The document concludes that identifying the specific cells where skin cancers begin is important for creating better prevention, detection, and treatment methods.

Exercise may help reduce treatment side effects and improve survival in metastatic colorectal cancer.

TGFβ's manipulation of inflammation and immune cells affects cancer spread, suggesting new treatment strategies and biomarkers.

Mutations in iRhom2 affect hair and skin in mice and are linked to esophageal cancer, with ADAM17 playing a crucial role.

Natural products can help overcome cancer drug resistance.

Steroid-producing capabilities in certain cancers may contribute to treatment resistance.

PCOS is linked to a higher risk of endometrial cancer but not ovarian or breast cancer, and more research is needed on its role in cancer development and treatment effects.

Extracellular vesicles and androgen receptors may help identify prostate cancer resistance and reduce SARS-CoV-2 infection.

Different types of skin cells play specific roles in development, healing, and cancer.

HPV genes and estradiol increase a cancer-related signaling pathway, which may be targeted for cervical cancer treatment.